|Over a week ago|
Fly Intel: Wall Street's top stories for Thursday » 16:4802/1302/13/20
AMZN, MSFT, TSLA, CSCO, FEYE, BABA, MGM, PEP, EFX, RDFN, HUBS, BE, SPWR, NUS
Stocks started the day…
Fly Intel: Wall Street's top stories at midday » 12:1602/1302/13/20
TSLA, CSCO, BABA, MGM, PEP, EFX, RDFN, HUBS, BE, SPWR, NUS
Stocks started the day…
Nu Skin falls -14.4% » 12:0002/1302/13/20
Nu Skin is down -14.4%,…
Nu Skin is down -14.4%, or -$5.16 to $30.63.
Nu Skin falls -15.5% » 10:0002/1302/13/20
Nu Skin is down -15.5%,…
Nu Skin is down -15.5%, or -$5.54 to $30.25.
Nu Skin falls -15.6% » 09:4702/1302/13/20
Nu Skin is down -15.6%,…
Nu Skin is down -15.6%, or -$5.57 to $30.22.
Nu Skin price target lowered to $35 from $42 at DA Davidson » 09:2902/1302/13/20
DA Davidson analyst Linda…
DA Davidson analyst Linda Weiser lowered her price target on Nu Skin to $35 after its in-line Q4 EPS and the 28% decline in its constant currency sales in China. The analyst notes that the company has suspended meetings in that market due to the coronavirus outbreak, driving its "big" expected 2020 earnings declines with no growth until Q4. Weiser adds that while Nu Skin's free cash flow may be below dividends, a payout cut is "highly unlikely" as she lowers the target valuation on the stock to 5.5-times from 6.0-times enterprise value to expected EBITDA.
Fly Intel: After Hours Movers » 19:0302/1202/12/20
ATOM, EDRY, RDFN, CRSP, AR, TRIP, CPA, AMAT, ASGN, CF, KGC, KERN, NUS, NTAP, TTGT, SPWR, LPI, RUSHA, CTL, CSCO, MGM, AVLR, MRO, ATUS, CHNG, QUOT, CDNS, EQIX, HEAR, TSLA
UP AFTER EARNINGS:…
UP AFTER EARNINGS: Atomera (ATOM) up 8.9%... EuroDry (EDRY) up 8.7%... Redfin (RDFN) up 6.6%... Crispr Therapeutics (CRSP) up 5.6%... Antero Resources (AR) up 4.5%... TripAdvisor (TRIP) up 4.1%... Copa Holdings (CPA) up 4.0%... Applied Materials (AMAT) up 2.9%... ASGN Inc (ASGN) up 2.1%... CF Industries (CF) up 1.9%... Kinross Gold (KGC) up 1.8%. DOWN AFTER EARNINGS: Akerna (KERN) down 15.0%... Nu Skin (NUS) down 14.3%... NetApp (NTAP) down 11.3%... TechTarget (TTGT) down 11.0%... SunPower (SPWR) down 7.7%... Laredo Petroleum (LPI) down 5.7%... Rush Enterprises (RUSHA) down 5.3%... CenturyLink (CTL) down 4.4%... Cisco (CSCO) down 4.1%... MGM Resorts (MGM) down 3.2%... Avalara (AVLR) down 2.9%... Marathon Oil (MRO) down 2.9%... Altice (ATUS) down 2.4%... Change Healthcare (CHNG) down 2.1%... Quotient Technology (QUOT) down 1.4%... Cadence Design (CDNS) down 1.2%... Equinix (EQIX) down 1.1%. ALSO LOWER: Turtle Beach (HEAR) down 7.4% after pre-announcing Q4 results... Tesla (TSLA) down 2.0% after reported recall of 15K Model X cars. Movers as of 18:30ET.
Nu Skin down 14% to $30.62 after FY20 guidance trails estimates 17:3002/1202/12/20
Nu Skin increases quarterly dividend to 37.5c per share from 37c per share » 16:2602/1202/12/20
Nu Skin has increased the…
Nu Skin has increased the quarterly cash dividend to 37.5c from the previous 37c per share. The quarterly dividend will be paid on March 11 to shareholders of record on Feb. 28.
Nu Skin sees FY20 EPS $2.00-$2.40, consensus $3.28 » 16:2502/1202/12/20
Sees FY2 0 revenue…
Sees FY2 0 revenue $2.17B-$2.30B, consensus $2.44B. CEO Wood stated, "In 2020, we are focused on building sales leaders by leveraging our technology enhancements and executing a strong product launch. We have an exciting product pipeline, including a new beauty device that we plan to introduce in the second half of the year, further expanding our top-ranked beauty device systems brand. We expect the momentum around this launch to provide opportunities to accelerate customer and sales leader acquisition. Given the global business environment we are also focused on increasing operational efficiencies. We are confident in our ability to return the business to growth and drive shareholder value. Following the recent coronavirus outbreak, we placed a temporary hold on all in-person meetings with our sales force and customers in Mainland China. We are closely monitoring this continuously evolving situation and following direction from government and health officials. While we expect the outbreak to significantly impact our business in the near term, we remain confident in our long-term opportunity in Mainland China and around the world. While the duration and global impact remain uncertain, our guidance reflects our current understanding of the situation. For the year, we are projecting a decline in sales in Mainland China of 20 to 25 percent and a negative foreign currency impact of 1 to 2 percent. We currently anticipate the overall business will return to growth in the fourth quarter of 2020, driven by the launch of a new beauty device".